Mir Claims USADA Cost Him “Millions” Due To False Positive

Frank Mir needed to wait nearly two years to fight after the former UFC heavyweight champion was suspended by USADA.

The fighter would leave the UFC and sign with Bellator due how his situation with their drug testing partner went down.

“I’ve lost millions,” Mir told RT Sport. “I had six more fights on a contract that paid me well. If you have noticed, my last fight, I didn’t even have sponsors. It’s difficult right now to rebuild up everything because of having to battle back from being falsely accused of something. It makes things difficult.”

Mir was suspended for two years for failing an in-competition drug test following his knockout loss to Mark Hunt in March 2016. The metabolite found that sent Mir to the suspension list is the same one Jon Jones would be found to have a year later.

”They’re still learning how the test works,” Mir said on how his case and Jones’ cases were handled. “I don’t think that you should have a test in the protocol that’s going to affect people’s careers – take two, four years away from them – and not fully understand it. And now they’re backtracking with Jon. ‘Well, you know, some of the tests are positive, some of the tests are negative. We don’t quite understand. It’s this pulsing’.”

“I’m screaming all these things, the same things Jon’s camp are screaming but, for whatever reason, I’m less believable – a less credible witness – I guess,” Mir said. “Jon is one of the greatest fighters in the world, pound for pound, but to be a less credible witness, that bothers me a little bit. That stings.”

“Now I guess there’s a new guy who has the metabolite found in his system, but they won’t release his name until they figure out what’s going on,” Mir said of the UFC’s new drug-testing protocol. “Well, that’s f****ing nice. I wish they’d have done that for me.”


Quotes Via MMA Mania

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More